Structure and inhibitor binding characterization of oncogenic MLLT1 mutants
X. Ni, A. T. Londregan, D. R. Owen, S. Knapp, A. Chaikuad
The paper reports crystal structures of oncogenic MLLT1 mutants, showing conformational changes and altered histone binding, but demonstrates that these mutants can still be targeted by acetyllysine mimetic inhibitors.
bioRxiv · Feb 8, 2021Biochemistry